Epidemiology of atopic dermatitis in adults: Results from an international survey

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 73, Issue 6, 2018, Pages 1284-1293

  Barbarot, S ^a   Auziere, S ^b   Gadkari, A ^c   Girolomoni, G ^d   Puig, L ^e   Simpson, E L ^f   Margolis, D J ^g   de Bruin Weller, M ^h   Eckert, L ⁱ  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b KANTAR HEALTH   (United States)

^c REGENERON PHARMACEUTICALS INC   (United States)

^d UNIVERSITY OF VERONA   (Italy)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ SANOFI   (France)

Author keywords

atopic dermatitis; epidemiology; prevalence; severity

Indexed keywords

ADULT; ARTICLE; ATOPIC DERMATITIS; CANADA; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; FRANCE; GERMANY; HUMAN; ITALY; JAPAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT ASSESSMENT; PATIENT GLOBAL ASSESSMENT; PATIENT ORIENTATED ECZEMA MEASURE; PATIENT ORIENTED SCORING OF ATOPIC DERMATITIS; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SKIN DISEASE ASSESSMENT; SPAIN; UNITED KINGDOM; UNITED STATES; YOUNG ADULT; ADOLESCENT; AGE; CLINICAL TRIAL; DISEASE MANAGEMENT; GLOBAL HEALTH; HEALTH SURVEY; MULTICENTER STUDY; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ADULT; AGE FACTORS; CROSS-SECTIONAL STUDIES; DERMATITIS, ATOPIC; DISEASE MANAGEMENT; FEMALE; GLOBAL HEALTH; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85041896926     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.13401     Document Type: Article

References (49)

1. Gittler JK, Shemer A, Suarez-Farinas M, et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol. 2012;130:1344-1354.
2. Brunner PM, Silverberg JI, Guttman-Yassky E, et al. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol. 2016;137:18-25.
3. Dharmage SC, Lowe AJ, Matheson MC, Burgess JA, Allen KJ, Abramson MJ. Atopic dermatitis and the atopic march revisited. Allergy. 2014;69:17-27.
4. Balkrishnan R, Housman TS, Grummer S, et al. The family impact of atopic dermatitis in children: the role of the parent caregiver. Pediatr Dermatol. 2003;20:5-10.
5. Chamlin SL, Chren MM. Quality-of-life outcomes and measurement in childhood atopic dermatitis. Immunol Allergy Clin North Am. 2010;30:281-288.
6. Fivenson D, Arnold RJ, Kaniecki DJ, Cohen JL, Frech F, Finlay AY. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J Manag Care Pharm. 2002;8:333-342.
7. Barbeau M, Lalonde H. Burden of Atopic dermatitis in Canada. Int J Dermatol. 2006;45:31-36.
8. Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European Countries. J Invest Dermatol. 2015;135:984-991.
9. Bender BG, Leung SB, Leung DY. Actigraphy assessment of sleep disturbance in patients with atopic dermatitis: an objective life quality measure. J Allergy Clin Immunol. 2003;111:598-602.
10. Wittkowski A, Richards HL, Griffiths CE, Main CJ. Illness perception in individuals with atopic dermatitis. Psychol Health Med. 2007;12:433-444.
11. Yano C, Saeki H, Ishiji T, et al. Impact of disease severity on sleep quality in Japanese patients with atopic dermatitis. J Dermatol Sci. 2013;72:195-197.
12. Yano C, Saeki H, Ishiji T, et al. Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis. J Dermatol. 2013;40:736-739.
13. Simpson EL, Bieber T, Eckert L, et al. Patient burden of moderate-to-severe atopic dermatitis: insights from a phase 2b clinical trial of dupilumab in adults. J Am Acad Dermatol. 2016;74:491-498.
14. Whiteley J, Emir B, Seitzman R, Makinson G. The Burden of Atopic Dermatitis in U.S. Adults: results from the 2013 National Health and Wellness Survey. Curr Med Res Opin. 2016;32:1645-1651.
15. Haeck IM, ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA, Knol MJ. Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2012;26:236-241.
16. Kim DH, Li K, Seo SJ, et al. Quality of life and disease severity are correlated in patients with atopic dermatitis. J Korean Med Sci. 2012;27:1327-1332.
17. Simpson E, Guttman-Yassky E, Margolis DJ, et al. Chronicity, comorbidity and life course impairment in atopic dermatitis: insights from a cross-sectional study in US Adults. Poster presented at the 25th European Academy of Dermatology and Venereology, September 28–October 2, 2016, Vienna, Austria. 2016.
18. Guttman-Yassky E, Simpson E, Margolis D, et al. Patient-reported disease burden in adults with atopic dermatitis: a US cross-sectional study. Poster presented at the 25th Congress of the European Academy of Dermatology and Venereology, Vienna, Austria, 28 September-2 October 2016. 2016.
19. Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis. J Am Acad Dermatol. 2016;75:681-687.
20. The World Allergy Organization (WAO). The World Allergy Organization (WAO) White Book on Allergy 2013 Update. 2013. http://www.worldallergy.org/UserFiles/file/WhiteBook2-2013-v8.pdf. Accessed on December 18, 2017.
21. Suarez-Varela MM, Alvarez LG, Kogan MD, et al. Diet and prevalence of atopic eczema in 6 to 7-year-old schoolchildren in Spain: ISAAC phase III. J Investig Allergol Clin Immunol. 2010;20:469-475.
22. Harrop J, Chinn S, Verlato G, et al. Eczema, atopy and allergen exposure in adults: a population-based study. Clin Exp Allergy. 2007;37:526-535.
23. Hanifin JM, Reed ML. A population-based survey of eczema prevalence in the United States. Dermatitis. 2007;18:82-91.
24. Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol. 2013;132:1132-1138.
25. Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC. Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. J Invest Dermatol. 2015;135:56-66.
26. Muto T, Hsieh SD, Sakurai Y, et al. Prevalence of atopic dermatitis in Japanese adults. Br J Dermatol. 2003;148:117-121.
27. DiBonaventura MD, Wagner JS, Yuan Y, L'Italien G, Langley P, Ray Kim W. Humanistic and economic impacts of hepatitis C infection in the United States. J Med Econ. 2010;13:709-718.
28. Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995;8:483-491.
29. Williams HC, Burney PG, Hay RJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol. 1994;131:383-396.
30. Williams HC, Burney PG, Pembroke AC, Hay RJ. Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party. Br J Dermatol. 1996;135:12-17.
31. Strina A, Barreto ML, Cunha S, et al. Validation of epidemiological tools for eczema diagnosis in Brazilian children: the ISAAC's and UK Working Party's criteria. BMC Dermatol. 2010;10:11.
32. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001;10:11-18.
33. Stalder JF, Barbarot S, Wollenberg A, et al. Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe. Allergy. 2011;66:1114-1121.
34. Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol. 2004;140:1513-1519.
35. Wollenberg A, Oranje A, Deleuran M, et al. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J Eur Acad Dermatol Venereol. 2016;30:729-747.
36. Charman CR, Venn AJ, Ravenscroft JC, Williams HC. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br J Dermatol. 2013;169:1326-1332.
37. Deville JC. A Theory of Quota Surveys. Surv Methodol. 1991;17:163-181.
38. Mortz CG, Andersen KE, Dellgren C, Barington T, Bindslev-Jensen C. Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities. Allergy. 2015;70:836-845.
39. Saeki H, Tsunemi Y, Fujita H, et al. Prevalence of atopic dermatitis determined by clinical examination in Japanese adults. J Dermatol. 2006;33:817-819.
40. Wolkewitz M, Rothenbacher D, Low M, et al. Lifetime prevalence of self-reported atopic diseases in a population-based sample of elderly subjects: results of the ESTHER study. Br J Dermatol. 2007;156:693-697.
41. Pesce G, Marcon A, Carosso A, et al. Adult eczema in Italy: prevalence and associations with environmental factors. J Eur Acad Dermatol Venereol. 2015;29:1180-1187.
42. Liang Y, Chang C, Lu Q. The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms. Clin Rev Allergy Immunol. 2016;51:315-328.
43. Ronmark EP, Ekerljung L, Lotvall J, et al. Eczema among adults: prevalence, risk factors and relation to airway diseases. Results from a large-scale population survey in Sweden. Br J Dermatol. 2012;166:1301-1308.
44. Zeppa L, Bellini V, Lisi P. Atopic dermatitis in adults. Dermatitis. 2011;22:40-46.
45. Baron SE, Morris PK, Dye L, Fielding D, Goulden V. The effect of dermatology consultations in secondary care on treatment outcome and quality of life in new adult patients with atopic dermatitis. Br J Dermatol. 2006;154:942-949.
46. Futamura M, Leshem YA, Thomas KS, Nankervis H, Williams HC, Simpson EL. A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: many options, no standards. J Am Acad Dermatol. 2016;74:288-294.
47. Schmitt J, Spuls P, Boers M, et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy. 2012;67:1111-1117.
48. Chalmers JR, Simpson E, Apfelbacher CJ, et al. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). Br J Dermatol. 2016;175:69-79.
49. Engebretsen KA, Johansen JD, Kezic S, Linneberg A, Thyssen JP. The effect of environmental humidity and temperature on skin barrier function and dermatitis. J Eur Acad Dermatol Venereol. 2016;30:223-249.